IFNG and neoplasm: We found that concomitant transfer of HSCs with tumor-specific T-cells significantly increases tumor-specific T-cell activation and IFNγ secretion within the tumor microenvironment (Fig. 3b) (p = 0.0110), and in draining lymph nodes relative to groups that received T-cells alone (Fig. 3c) (p = 0.002).